STAT

NOVEMBER 24, 2023

Reports this week that China is experiencing a surge in respiratory infections in young children triggered flashbacks of the start of the Covid-19 pandemic among infectious disease watchers. But a rapidly organized meeting Thursday between the World Health Organization and health officials in China assuaged much of that concern. The evidence presented to the WHO team pointed to what’s sometimes called an immunity gap that was created by the pandemic.

Immunity 363

Immunity Immunization 363

Pharma Times

NOVEMBER 24, 2023

Around 3,200 new cases of cervical cancer are diagnosed in the UK every year - News - PharmaTimes

128

128

STAT

NOVEMBER 24, 2023

UnitedHealth Group’s Optum division is already the largest employer of physicians in the United States, but allegations in a new lawsuit suggest Optum is hungry for more. Emanate Health, a nonprofit group of hospitals and physicians in California, filed a federal lawsuit Monday, alleging Optum pushed it to agree not to compete for primary care physicians, a violation of antitrust law.

Hospitals 359

Hospitals 359

Pharma Times

NOVEMBER 24, 2023

The findings could benefit patients living with neurodegenerative conditions - News - PharmaTimes

121

121

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

STAT

NOVEMBER 24, 2023

I had only lived in Kibera for 15 minutes when I saw a police officer and was arrested. But it would be years before I saw a real doctor. In 2001, at the age of 13, I had come to Kenya’s largest informal settlement on the outskirts of Nairobi with my sister. When we arrived at 3 a.m., we dutifully called my uncle from a phone booth to pick us up.

280

280

pharmaphorum

NOVEMBER 24, 2023

How to optimise commercial-scale ATMP manufacturing through automation Mike.

118

118

European Pharmaceutical Review

NOVEMBER 24, 2023

Amgen’s new immunotherapeutic agent Tarlatamab has been shown in a Phase II trial to provide sustained anti-tumour activity in 40 percent of the small cell lung cancer patients. The international DeLLphi-301study was investigated as a new anti-cancer treatment option for patients previously considered to be beyond treatment. Results from the trial were published in the New England Journal of Medicine.

Hospitals 116

Hospitals Dosage 116

pharmaphorum

NOVEMBER 24, 2023

International Health Partners' Christmas campaign: Working with pharma for patients worldwide Nicole.

110

110

PharmaTech

NOVEMBER 24, 2023

The largest biotech hub is set to be built in Lithuania by Northway Group.

106

106

Pharmaceutical Technology

NOVEMBER 24, 2023

Bayer announced the launch of a Berlin, Germany-based manufacturing facility to meet future demands from the US, China and Europe.

105

105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharmafile

NOVEMBER 24, 2023

Alladapt Immunotherapeutics has announced that ADP101 has received Fast Track Designation from the US Food and Drug Administration (FDA) as a treatment for one or more food allergens. ADP101 is currently the most advanced multi-food oral immunotherapy (mOIT) candidate in development, and there are currently no FDA-approved OIT treatments for multi-food allergy to foods other […] The post Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment appea

105

105

Express Pharma

NOVEMBER 24, 2023

The 16 th edition of CPHI & PMEC India Expo, organised by Informa Markets in India, will be held from November 28-30, 2023, at the India Expo Centre in Greater Noida, Delhi. CPHI & PMEC India, along with its ancillary programmes, spotlights technological strides pivotal in propelling India’s pharma machinery, technology, and ingredients sectors.

Packaging 105

Packaging Vaccines Pharmaceutical Manufacturing Hospitals 105

The Pharmacist

NOVEMBER 24, 2023

Service specifications and patient group directions (PGDs) for the extended Community Pharmacy Contraceptive Service and Hypertension Case Finding Service have been published on the NHS England (NHSE) website. Under new rules, from 1 December community pharmacies will be able to initiate oral contraception, and all suitably trained members of the pharmacy team will be able […] The post NHS unveils specifications and PGDs for new pharmacy services appeared first on The Pharmacist.

Community Pharmacies 102

Community Pharmacies 102

European Pharmaceutical Review

NOVEMBER 24, 2023

Novo Nordisk is investing over €2.1 billion (16 billion Danish kroner) to expand its production site in Chartres, France, supporting manufacture of its products for serious chronic diseases. Novo Nordisk’s multi-billion facility expansion This financial commitment will greatly strengthen manufacturing capacity, more than doubling the site’s footprint.

Pharmaceutical Manufacturing 98

Pharmaceutical Manufacturing Packaging 98

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Outsourcing Pharma

NOVEMBER 24, 2023

Calliditas Therapeutics AB announced today (November 24) that its partner Everest Medicines has revealed that China's National Medical Products Administration (NMPA) has approved Nefecon.

83

83

European Pharmaceutical Review

NOVEMBER 24, 2023

The European Commission has granted a label expansion of the combination treatment KAFTRIO ® (ivacaftor/tezacaftor/elexacaftor) with ivacaftor, for children aged two to five years old with cystic fibrosis. The treatment from Vertex Pharmaceuticals is indicated for individuals who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator ( CYSTIC FIBROSISTR ) gene.

Labelling 98

Labelling 98

Outsourcing Pharma

NOVEMBER 24, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson announced last week (November 23) the submission of a type 2 extension of indication application to the European Medicines Agency (EMA).

Pharmaceutical Companies 78

Pharmaceutical Companies Pharmaceutical Companies 78

The Pharmacist

NOVEMBER 24, 2023

Independent pharmacies are increasingly closing their doors because of ongoing funding pressures, leaving patients unsure where to turn to, an influential committee of MPs has been told. Vice chair of the National Pharmacy Association Jay Badenhorst told the Health and Social Care Committee earlier this week that ‘for a lot of independent businesses, there is […] The post Patients left ‘unsure where to turn to’ amid increasing pharmacy closures appeared first on The Pharmacist.

Independent Pharmacies 69

Independent Pharmacies 69

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

World Pharma News

NOVEMBER 24, 2023

Lidocaine - often used as numbing agent for outpatient medical procedures - activates certain bitter taste receptors through two unique mechanisms that result in cancer cell death, according to researchers from the Perelman School of Medicine at the University of Pennsylvania. Their findings, published in Cell Reports, pave the way for a clinical trial to test the addition of lidocaine to the standard of care therapy for patients with head and neck cancers.

63

63

Pharmacy Times

NOVEMBER 24, 2023

In part 2 of this series, trauma-informed pharmacist Helen Sairany, PharmD, MBA, discusses the physical manifestations of burnout.

59

59

Drug Patent Watch

NOVEMBER 24, 2023

This chart shows the drugs with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Pharmacy Times

NOVEMBER 24, 2023

For pharmacists and pharmacy technicians, who work diligently to ensure our health and well-being, choosing the perfect holiday gift can be a thoughtful way to express gratitude and brighten their season.

Pharmacy Technician 59

Pharmacy Technician 59

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Drug Patent Watch

NOVEMBER 24, 2023

Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are twenty-six patents protecting… The post New patent for Abbvie drug RINVOQ appeared first on DrugPatentWatch - Make Better Decisions.

59

59

pharmaphorum

NOVEMBER 24, 2023

NHS Confederation, ABPI say break down barriers to partnerships and change the lives of millions Nicole.

59

59

Drug Patent Watch

NOVEMBER 24, 2023

Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29 Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are… The post New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Pharmaceutical Business Review

NOVEMBER 24, 2023

A therapy platform developed by T3 Pharma using engineered Yersinia enterocolitica bacteria, delivers immune-modulating proteins to cancer cells and tumour micro-environments, sparing healthy tissues. The bacteria can be loaded with several selective immune-modulatory proteins, enabling the design of immuno-oncology combination therapies in one single agent.

Immunity 59

Immunity Immunization 59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

NOVEMBER 24, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for F. Hoffmann-La Roche here.

59

59

pharmaphorum

NOVEMBER 24, 2023

Intellectual property: Striking the balance Mike.

59

59

Pharmaceutical Technology

NOVEMBER 24, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Johnson & Johnson here.

59

59

Pharmafile

NOVEMBER 24, 2023

Freeline Therapeutics has announced that it has entered into a definitive agreement with newly established portfolio company Syncona, in which Syncona will acquire Freeline in an all-cash transaction. Syncona will pay $6.50 per share, or an approximate total of $28.3m. The acquisition is expected to close in the first quarter of 2024, although it is […] The post Syncona to acquire Freeline Therapeutics for $28.3m appeared first on Pharmafile.

59

59

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management